Posts

Digital tool to help identify cancer patients at risk of serious immunotherapy side effect

on

Roche's Fenebrutinib Delays MS Relapses in Phase 3 Trials but Faces Liver Toxicity and Safety Scrutiny

on

Patient Hospitalized After Receiving Intellia's CRISPR Therapy Dies, Prompting FDA Hold on Trials

on

Intellia Pauses Two CRISPR Trials After Severe Liver Toxicity Hospitalizes Patient

on

Zymeworks Halts Development of ZW171 T-cell Engager After Phase 1 Trial Assesses Benefit-Risk Profile

on

FDA Advisory Committee Votes Against GSK's Blenrep in Multiple Myeloma

on

FDA Flags Eye Safety Concerns as GSK Seeks Blenrep's US Return

on

FDA Investigates Patient Deaths Linked to Sarepta's Elevidys Gene Therapy for Duchenne Muscular Dystrophy

on

FDA puts Vyne in a twist, slapping hold on psoriasis trial over testicular toxicity concerns

on